 infectious hematologic otolaryngic complications myelosuppressive cancer chemotherapy otolaryngologist-head neck surgeon patients administration myelosuppressive cancer chemotherapy Fifty consecutive patients University Pennsylvania Oncology Center chemotherapy adult leukemia bone marrow transplantation Otolaryngic history physical examination radiographic studies hematologic surveys duration therapy attempt risk factors infectious hematologic otolaryngic complications Two-thirds patient experienced untoward effects attention otolaryngologist-head neck surgeon various complications correlations study parameters chemotherapy